245 related articles for article (PubMed ID: 29932342)
1. The bitter side of epigenetics: variability and resistance to chemotherapy.
Hajji N; García-Domínguez DJ; Hontecillas-Prieto L; O'Neill K; de Álava E; Syed N
Epigenomics; 2021 Mar; 13(5):397-403. PubMed ID: 29932342
[TBL] [Abstract][Full Text] [Related]
2. Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms.
Mora Y; Reyes ME; Zanella L; Mora B; Buchegger K; Ili C; Brebi P
Pharmacogenomics; 2021 Aug; 22(12):777-790. PubMed ID: 34281355
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer.
Borley J; Brown R
Ann Med; 2015; 47(5):359-69. PubMed ID: 26158617
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics and oncology.
Mummaneni P; Shord SS
Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in cancer stem cells.
Toh TB; Lim JJ; Chow EK
Mol Cancer; 2017 Feb; 16(1):29. PubMed ID: 28148257
[TBL] [Abstract][Full Text] [Related]
6. Using Epigenetic Therapy to Overcome Chemotherapy Resistance.
Strauss J; Figg WD
Anticancer Res; 2016 Jan; 36(1):1-4. PubMed ID: 26722021
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistance.
Ponnusamy L; Mahalingaiah PKS; Singh KP
Adv Clin Chem; 2020; 94():219-259. PubMed ID: 31952572
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic programming contributes to development of drug resistance in hematological malignancies.
Wang QY; Zhong H
Front Biosci (Landmark Ed); 2015 Jan; 20(4):728-42. PubMed ID: 25553475
[TBL] [Abstract][Full Text] [Related]
10. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements.
Singh D; Khan MA; Siddique HR
Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
12. Cancer's epigenetic drugs: where are they in the cancer medicines?
Ghasemi S
Pharmacogenomics J; 2020 Jun; 20(3):367-379. PubMed ID: 31819161
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic targeting therapies to overcome chemotherapy resistance.
Balch C; Nephew KP
Adv Exp Med Biol; 2013; 754():285-311. PubMed ID: 22956507
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic alternations and cancer chemotherapy response.
Lv JF; Hu L; Zhuo W; Zhang CM; Zhou HH; Fan L
Cancer Chemother Pharmacol; 2016 Apr; 77(4):673-84. PubMed ID: 26707728
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
16. Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators.
Rauscher S; Greil R; Geisberger R
Curr Cancer Drug Targets; 2021; 21(4):353-359. PubMed ID: 33423645
[TBL] [Abstract][Full Text] [Related]
17. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
[TBL] [Abstract][Full Text] [Related]
18. Role of epigenome in tumorigenesis and drug resistance.
Hu Q; Baeg GH
Food Chem Toxicol; 2017 Nov; 109(Pt 1):663-668. PubMed ID: 28709969
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
Shah K; Rawal RM
Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
[TBL] [Abstract][Full Text] [Related]
20. Reversing aberrant methylation patterns in cancer.
Poke FS; Qadi A; Holloway AF
Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]